Standard Life has delivered a powerful run over the past few years, and the share price strength puts fresh focus on a simple question for investors: Is the current valuation of the stock properly anchored in the level of sales the business is generating?
The stock’s next move may depend on whether the current share price for Standard Life is fully justified by its sales.
If you are weighing whether Standard Life’s valuation leaves much headroom, it can help to see how other stocks with solid balance sheets and fundamentals are currently priced through the solid balance sheet and fundamentals stocks screener (8 results).
The P/S ratio fits Standard Life well because investors often look at revenue-based metrics for insurance groups where accounting earnings can be noisy. Right now, the stock trades on a P/S of about 0.2x, which is far below the insurance industry average of 1.1x and also trails a peer group closer to 1.9x.
Even after the strong share price run, that gap suggests the market is paying a relatively low amount for each £1 of Standard Life’s sales. On the Excess Returns framework, a business with this profile would typically be expected to trade on a higher P/S than today’s level. This points to the shares screening as undervalued on this metric. For anyone weighing the next move, the open question is whether the quality and durability of those revenues justify the multiple staying where it is or drifting closer to that fair range. Explore the numbers behind Standard Life's P/S valuation.
Simply Wall St Narratives pick up where Standard Life's valuation puzzle leaves off by spelling out which paths for future growth, margins and earnings would need to hold for the stock to be worth materially more or less than it is today on the market. Each storyline links a specific fair value to a clear set of potential catalysts and risks for Standard Life, so you can watch over time which version of events seems to be unfolding.
Standard Life attracts two very different reads, with one view seeing extra upside in the story and the other arguing expectations already look full.
Bull case: 16% undervalued
This view comes from the bullish analyst Narrative on Simply Wall St, which leans hardest into the upside scenario.
"The current valuation implies the share price does not fully reflect the company’s shift toward capital-light pensions and savings earnings, rising operating profit and OCG, and the additional fee streams from Aegon U.K. and the PRT partnership…"
Discover why this Narrative puts Standard Life at 16% undervalued.
Bear case: roughly fairly valued
The analyst consensus Narrative on Simply Wall St sees the set up as more balanced for Standard Life at today’s level.
"The current valuation suggests that the market views Standard Life as fairly valued with a bullish tilt, based on strong solvency, excess cash generation and the Aegon UK deal supporting earnings and shareholder returns beyond 2026…"
Explore why this Narrative puts Standard Life at roughly fairly valued.
Valuation only tells you what investors pay today. The real curiosity is how professional analysts currently map out Standard Life’s profit and revenue profile a few years from now. Explore where analysts expect Standard Life to be in a few years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com